Patents by Inventor Phyllis Carolyn Leppert

Phyllis Carolyn Leppert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment Method and Product for Uterine Fibroids using Purified Collagenase
    Publication number: 20240082164
    Abstract: The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
    Type: Application
    Filed: November 20, 2023
    Publication date: March 14, 2024
    Inventors: Phyllis Carolyn LEPPERT, Thomas L. WEGMAN
  • Treatment of uterine fibroids using purified collagenase
    Patent number: 11872267
    Abstract: Disclosed herein are compositions and methods for treating uterine fibroids in vivo, and methods of reducing symptoms associated with uterine fibroids, including pain, bleeding and infertility. The disclosed compositions comprise collagenase in an amount effective to cause shrinkage and/or reduce stiffness of uterine fibroids.
    Type: Grant
    Filed: October 14, 2020
    Date of Patent: January 16, 2024
    Assignees: The Johns Hopkins University, Duke University, BioSpecifics Technologies LLC
    Inventors: James H. Segars, Phyllis Carolyn Leppert, Thomas L. Wegman, Jean-Marie Soma
  • Treatment method and product for uterine fibroids using purified collagenase
    Patent number: 11857685
    Abstract: Compositions and methods for treating uterine fibroids are described, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
    Type: Grant
    Filed: April 5, 2021
    Date of Patent: January 2, 2024
    Assignees: BioSpecifics Technologies LLC, Duke University
    Inventors: Phyllis Carolyn Leppert, Thomas L. Wegman
  • Treatment Method and Product for Uterine Fibroids using Purified Collagenase
    Publication number: 20210220284
    Abstract: The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
    Type: Application
    Filed: April 5, 2021
    Publication date: July 22, 2021
    Applicants: BIOSPECIFICS TECHNOLOGIES CORP., DUKE UNIVERSITY
    Inventors: Phyllis Carolyn LEPPERT, Thomas L. WEGMAN
  • Treatment of Uterine Fibroids using Purified Collagenase
    Publication number: 20210113670
    Abstract: The invention relates to compositions and methods for treating uterine fibroids in vivo, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage and/or reduce stiffness of uterine fibroids is injected or inserted into the uterine fibroid. The invention also relates to methods of reducing symptoms associated with uterine fibroids, including pain, bleeding and infertility.
    Type: Application
    Filed: October 14, 2020
    Publication date: April 22, 2021
    Applicants: The Johns Hopkins University, Duke University, BioSpecifics Technologies Corp.
    Inventors: James H. Segars, Phyllis Carolyn Leppert, Thomas L. Wegman, Jean-Marie Soma
  • Treatment Method and Product for Uterine Fibroids using Purified Collagenase
    Publication number: 20210023014
    Abstract: The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
    Type: Application
    Filed: October 6, 2020
    Publication date: January 28, 2021
    Applicants: BioSpecifics Technologies Corp., Duke University
    Inventors: Phyllis Carolyn Leppert, Thomas L. Wegman
  • Treatment Method and Product for Uterine Fibroids using Purified Collagenase
    Publication number: 20200078310
    Abstract: The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
    Type: Application
    Filed: July 9, 2019
    Publication date: March 12, 2020
    Applicants: BIOSPECIFICS TECHNOLOGIES CORP., DUKE UNIVERSITY
    Inventors: Phyllis Carolyn LEPPERT, Thomas L. WEGMAN
  • Treatment method and product for uterine fibroids using purified collagenase
    Patent number: 10369110
    Abstract: The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 6, 2019
    Assignees: BioSpecifics Technologies Corporation, Duke University
    Inventors: Phyllis Carolyn Leppert, Thomas L. Wegman
  • Treatment Method and Product for Uterine Fibroids using Purified Collagenase
    Publication number: 20170333356
    Abstract: The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
    Type: Application
    Filed: August 1, 2017
    Publication date: November 23, 2017
    Applicants: BioSpecifics Technologies Corp., Duke University, North Carolina Central University
    Inventors: Phyllis Carolyn Leppert, Thomas L. Wegman, Darlene K. Taylor
  • Treatment method and product for uterine fibroids using purified collagenase
    Patent number: 9744138
    Abstract: The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 29, 2017
    Assignees: BioSpecifics Technologies Corp., Duke University, North Carolina Central University
    Inventors: Phyllis Carolyn Leppert, Thomas L. Wegman, Darlene K. Taylor
  • Treatment Method and Product for Uterine Fibroids using Purified Collagenase
    Publication number: 20140287032
    Abstract: The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 25, 2014
    Applicants: Duke University, BioSpecifics Technologies Corp.
    Inventors: Phyllis Carolyn Leppert, Thomas L. Wegman
  • Treatment Method and Product for Uterine Fibroids using Purified Collagenase
    Publication number: 20140271612
    Abstract: The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicants: DUKE UNIVERSITY, BIOSPECIFICS TECHNOLOGIES CORP.
    Inventors: Phyllis Carolyn Leppert, Thomas L. Wegman